source
- Lilly shares slide as Foundayo prescriptions lag expectations, while Novo's Wegovy gains momentumEli Lilly's stock fell nearly 5% after the latest weekly prescription count for its obesity drug Foundayo missed analysts' expectations. IQVIA data showed U.S. prescriptions for Foundayo reached 3…
- FDA grants fast-track vouchers to three psychedelic firmsThe FDA announced it has issued fast-track development vouchers to three companies working on psychedelic therapies. The recipients are R&DCompass, Transcend, and the Usona Institute. The vouchers…